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Abstract
Background: Glioblastoma multiforme (GBM) is the deadliest malignant primary brain tumor in adults. GBM
develops primarily in the cerebral hemispheres but can develop in other parts of the central nervous system. Its
congenital variant is a very rare disease with few cases described in literature.
Case presentation: We describe the case of a patient with congenital GBM who developed eruptive disseminated
Spitz nevi (EDSN) after chemotherapy. Few cases of EDSN have been described in literature and this rare clinical
variant, which occurs predominantly in adults, is characterized by multiple Spitz nevi in the trunk, buttocks, elbows
and knees. There is no satisfactory treatment for EDSN and the best therapeutic choice is considered the clinical
observation of melanocytic lesions.
Conclusion: We recommend a close follow-up of these patients with clinical observation, dermoscopy and
reflectance confocal microscopy (RCM). However, we suggest a surgical excision of the lesions suspected of being
malignant.
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Background
Case reports and small case series of congenital glioblast-
oma multiforme (GBM) have suggested variable survivals,
with the large majority of patients dying within weeks to
months, but occasional patients survive for years [1]. The
treatment is the result of an effective teamwork based on
neurosurgery, chemotherapy and radiation therapy [1, 2].
We describe the case of a patient with congenital GBM
who developed eruptive disseminated Spitz nevi (EDSN)
after chemotherapy.
Case Presentation
A male neonate was born at 38 weeks’ gestation by
vaginal delivery with vacuum extraction. Pregnancy was
uneventful. Birth weight was 3290 g. The baby at birth
was pale, hypotonic, bradycardiac, without spontaneous
breathing and was promptly intubated. The Apgar score
was 3, 6 and 6 at 1st, 5th and 10th minute respectively.
Three hours after birth the neonate was referred to a
neonatal intensive care unit. Due to intrapartum as-
phyxia the neonate was treated with hypothermia for
72 hours. Brain ultrasound scan (day 1) showed bilateral
severe intraventricular hemorrhage (grade 3), while mag-
netic resonance imaging (day 4) revealed hydrocephalus
with an extensive haematoma in the frontal lobes. The
morphology of the bleeding was atypical, therefore a
brain tumor was suspected to be the source of bleeding.
An increasing ventricular dilatation was observed in the
following days, therefore on day 7 haematoma was
drained, an intraventricular catheter with an external
shunt was placed and multiple biopsies were performed.
The postoperative course was uneventful with the im-
provement of the hydrocefalus. Two days after surgery
the baby was extubated and enteral feeding was started.
Basing on the diagnosis of congenital GBM, confirmed
by histology, on day 16 the external shunt was replaced
with a reservoir (Ommaya). After positioning a central
venous catheter (Broviac type monolumen) in the right
atrium, chemotherapy was started at age 18 days and the
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patient was treated under the two-phase AIEOP Infant
High Risk-CNS tumor protocol. Doses were adjusted for
weight. The four-course Phase A included: methotrexate
250 mg/kg plus vincristine 0.04 mg/kg; etoposide
80 mg/kg; cyclophosphamide 135 mg/kg plus vincristine
0.04 mg/kg; carboplatin 25 mg/kg. Peripheral blood stem
cells (PBSC) were collected for rescue therapy. Phase B
included two high-dose chemotherapy regimens plus
PBSC support: carboplatin 50 mg/kg plus etoposide
50 mg/kg; thiotepa 10 mg/kg/day plus melphalan 4 mg/
kg/day. Common toxicity criteria (CTC) were adopted.
Elevated transaminase levels (grade III) were observed
after high dose methotrexate. Grade III anaemia and
grade IV thrombocytopenia developed after the second
(etoposide) and third (cyclophosphamide and vincristine)
courses. Granulocyte colony stimulating factors (G-CSF)
were given from day 35 to day 38. At the end of treatment
hematopoietic stem cells were collected. On day 40 the
reservoir was replaced with a ventricle-peritoneal drain-
age. The postoperative course was uneventful. A second
curse of chemotherapy was started on day 48. After com-
pletion of treatment the clinical course was uneventful.
To date no neurological impairments have been observed:
development status, as assessed by motor, cognitive and
social adaptive skills on the Clinical, Linguistic and Audi-
tory Milestones (CLAM) scale, showed no significant
differences from the normal range. The patient was born
without any nevus clinically evident. From the age of 1 year
some nevi appeared, mainly on his trunk and back.
Because of the progressive increase in number and dimen-
sion of the pigmented skin lesions the child was sent to
our attention for a dermatologic exam at the age of
16 months. The nevi had light-brown to black colour, with
variable morphology and dimension from 2 mm to 21 mm,
manly located on the trunk. The dermoscopic exam of
these lesions revealed multiple atypical nevi characterized
by a starburst pattern, globular pattern or multicomponent
pattern [3, 4] with asymmetrical hypo-pigmented area
and irregular borders. These dermatoscopic features
correspond to Spitz nevi [3, 4]. To confirm our diag-
nostic suspicious we also performed the reflectance
confocal microscopy (RCM) (VivaScope 1500®: Caliber
I.D., Rochester, USA), which revealed in the nevi with
starburst pattern (Fig. 1) and globular pattern (Fig. 2)
the typical dense regular nests at the dermoepidermal
junction and in the papillary dermis, while in the epi-
dermis showed regular cobblestone with rare spindled
and atypical cells [4]. Instead, the multicomponent
Fig. 1 Spitz nevus localized on the shoulder (a). Dermoscopy showed a starbust pattern with multiple pigmented striations and large brown globules
distributed symmetrically at the periphery of the lesion (b). RCM revealed in the epidermis regular cobblestone with rare spindled (white arrow) and
atypical cells (red arrow) (c). Instead at the dermoepidermal junction and within the papillary dermis showed the typical dense regular nests (yellow
arrows). Moreover, papillary dermis presented edged papillae (green arrows) (d)
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pattern (Fig. 3) with RCM was characterized by irregu-
lar cobblestone with spindled and atypical cells in the
epidermis, nonedged papillae and plump bright cells at
the dermoepidermal junction and in the papillary der-
mis [4]. Therefore, we made a diagnosis of EDSN. We
decided to perform a strict follow-up of the numerous
Spitz nevi instead of performing multiple excisions. Never-
theless, during the follow-up we removed one lesion with
multicomponent pattern (Fig. 3) suspected to be malig-
nant which resulted to be a Spitz nevus at histopatho-
logical examination. Currently the patient is 3 years old
and in the follow-up was not noted any changement in
pattern and all nevi on dermoscopy were stable. In the
follow-up carried out until now there has been observed
the onset of new Spitz nevi.
Discussion
Congenital GBM is a rare disease that accounts for only
3 % of congenital brain tumors and less than 30 cases
have been reported in literature [1]. It is a very aggressive
tumor with limited survival rates [1, 2]. The cause of
the disease is unknown [2]. Patients with congenital
GBM should undergo optimal surgical resection, radiation
therapy and chemotherapy with different therapeutic
approaches based on tumor extent and location [1, 2].
The Spitz nevus clinically appears as light-brown to black
macule or papule, usually localized on the buttocks, arms
or legs [3]. This nevus can reach size up to 5 mm in diam-
eter [3, 4]. Spitz nevi are classified into 3 clinical variants:
solitary, agminated and EDSN [3, 4]. The most common
clinical variant is the solitary Spitz nevus, which occurs
in children, and is usually localized on the neck or head
[3, 4]. The agminated variant is characterized by Spitz
nevi, which arise on congenital hypopigmented, and
hyperpigmented patches. These lesions are commonly
localized on the face and arms, with less frequent in-
volvement of the thighs, neck, shoulders and other sites
[5]. The EDSN is a rare clinical variant, which occurs
predominantly in the adult, characterized by multiple
Spitz nevi in the trunk, buttocks, elbows and knees [6].
The scalp, mucous membranes, palms and soles are
usually spared. In the EDSN is possible to observe the
development of more than 100 Spitz nevi, over a period
of several months or years [6, 7]. To best of our know-
ledge only 15 cases of EDSN have been described in litera-
ture [7–9]. Generally, on dermoscopy the Spitz nevi shows
three dermoscopic patterns: starburst, globular and multi-
component [3, 4]. Starburst pattern is characterised by
Fig. 2 Spitz nevus localized on the trunk (a). Dermoscopy showed a globular pattern with regular, brownish central pigmentation and brownish
globules at the periphery of the lesion (b). RCM revealed in the epidermis regular cobblestone with rare spindled (white arrow) and atypical cells
(red arrow) (c). Instead at the dermoepidermal junction and within the papillary dermis showed the typical dense regular nests (yellow arrows).
Moreover, papillary dermis presented edged papillae (green arrows) (d)
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multiple pigmented striations and/or large brown or
black globules distributed symmetrically along the mar-
gins of the lesion, with a radiated appearance. Globular
pattern is represented by regular brownish or greyish
central pigmentation and brownish globules along the
margins. Multicomponent pattern is characterized by
irregular distribution of structures and colours, areas of
diffuse, irregular pigmentation and a whitish-blue veil.
RCM is a non-invasive imaging method for evaluating
benign and malignant skin lesions and has a wide area
of use in basic and clinical dermatology [10, 11]. RCM al-
lows horizontal visualization of epidermis and superficial
dermis with a nearly histologic resolution [4, 10, 11]. The
typical aspects of Spitz nevi at RCM were previously de-
scribed [4]. The cause of EDSN is still unknown, al-
though a number of possible precipitating factors have
been described in the literature, including pregnancy,
intravenous drug abuse, perioperative stress, Addison
disease, ultraviolet light exposure and fever following
tonsillectomy [7, 12]. After chemotherapy a conspicu-
ous eruption of multiple nevi has been reported in
literature [13, 14]. Dysplastic nevi and malignant mel-
anoma have been described in literature with concurrent
or prior immunosuppressive states, such as in HIV infec-
tion, after renal transplantation and after chemotherapy,
especially in children and young adults [13, 14]. In our
case we hypothesize that EDSN is correlate with the
chemotherapy. In detail we think that a plausible explan-
ation of EDSN is the induction of nevocytic nevi by cyto-
static agents. In fact cytostatic agents are mutagenic and
can activate primordial nevus cell nests. To the best of our
knowledge, there is no case of malignant transformation
of Spitz nevi to melanoma in patients affected by EDSN
[5–9, 12, 15]. Surgical removal of individual melanocytic
lesions is possible but, due to the large number and poor
cosmetic results, is not considered a good option for
EDSN. Other treatment options adopted in the past are
the liquid nitrogen, electrocoagulation and imiquimod [7,
15]. However, there is no satisfactory treatment for EDSN.
Currently the best therapeutic choice is considered the
clinical observation of melanocytic lesions.
Conclusion
Patients with a history of multiple agent chemotherapy for
treatment of pediatric malignancies have an increasing
incidence of clinically and histologically multiple nevi,
atypical nevi and malignant melanoma. We recommend a
close follow-up of these patients with clinical observation,
dermoscopy and RCM. However, we suggest the excision
of lesions suspected of being malignant.
Fig. 3 Spitz nevus localized on the back (a). Dermoscopy showed a multicomponent pattern with irregular pigmentation and a whitish-blue
veil (b). RCM revealed in the epidermis irregular cobblestone with spindled (white arrows) and atypical cells (red arrows) (c). Instead at the
dermoepidermal junction and within the papillary dermis showed nonedged papillae (green arrows) and plump bright cells (yellow arrows) (d)
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